Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Ann Thorac Surg ; 113(4): e311-e313, 2022 04.
Article in English | MEDLINE | ID: mdl-34418343

ABSTRACT

We present a new technique for percutaneous retrieval of a U-kinked displaced Impella catheter. First we used the hooker from the left femoral artery to snare the catheter tip. Both catheter and hooker were pulled down simultaneously from 2 opposite sites until the U-kinking sat astride the aortic bifurcation. Finally the loop was straightened by pulling both catheter and hook. Once unfolded the hook was released, and the catheter was retrieved easily from the right femoral artery. This technique is highly reproducible because of several advantages. It is easy to perform, takes a short time, does not require special devices, and is not expensive.


Subject(s)
Catheters , Femoral Artery , Humans
2.
J Card Surg ; 35(11): 3176-3178, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32743871

ABSTRACT

The third case reported in the literature of a left atrial neoplasm characterized by a very deceptive, low grade cellular component at its early stage of growth, so as to be diagnosed as a myxoma is presented. Two months after surgical excision, regrowth of the mass occurred, producing a pancreatic mass also. The new atrial mass was excised; a left atrial myxoid sarcoma and a pancreatic metastasis were diagnosed. One week later the atrial sarcoma grew again. This time surgery was contraindicated and the patient underwent chemotherapy with a satisfactory control of the sarcoma growth. The myxoid sarcoma may present with the deceptive appearance of a myxoma in their early stages. Therefore, patients who have undergone surgical removal of a myxoma should have a close follow-up to monitor unexpected malignant turnover.


Subject(s)
Heart Neoplasms/pathology , Heart Neoplasms/surgery , Myxoma/surgery , Pancreatic Neoplasms/secondary , Pancreatic Neoplasms/surgery , Sarcoma/secondary , Sarcoma/surgery , Diagnosis, Differential , Echocardiography , Heart Atria , Heart Neoplasms/diagnosis , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Myxoma/diagnosis , Myxoma/pathology , Pancreatic Neoplasms/pathology , Sarcoma/diagnosis , Sarcoma/pathology , Treatment Outcome
3.
Perfusion ; 32(3): 245-252, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28327076

ABSTRACT

BACKGROUND: Myocardial damage is an independent predictor of adverse outcome following cardiac surgery and myocardial protection is one of the key factors to achieve successful outcomes. Cardioplegia with Custodiol is currently the most used cardioplegia during minimally invasive cardiac surgery (MICS). Different randomized controlled trials compared blood and Custodiol cardioplegia in the context of traditional cardiac surgery. No data are available for MICS. AIM: The aim of this study was to compare the efficacy of cold blood versus Custodiol cardioplegia during MICS. METHOD: We retrospectively evaluated 90 patients undergoing MICS through a right mini-thoracotomy in a three-year period. Myocardial protection was performed using cold blood (44 patients, CBC group) or Custodiol (46 patients, Custodiol group) cardioplegia, based on surgeon preference and complexity of surgery. RESULTS: The primary outcomes were post-operative cardiac troponin I (cTnI) and creatine kinase MB (CKMB) serum release and the incidence of Low Cardiac Output Syndrome (LCOS). Aortic cross-clamp and cardiopulmonary bypass times were higher in the Custodiol group. No difference was observed in myocardial injury enzyme release (peak cTnI value was 18±46 ng/ml in CBC and 21±37 ng/ml in Custodiol; p=0.245). No differences were observed for mortality, LCOS, atrial or ventricular arrhythmias onset, transfusions, mechanical ventilation time duration, intensive care unit and total hospital stay. CONCLUSIONS: Custodiol and cold blood cardioplegic solutions seem to assure similar myocardial protection in patients undergoing cardiac surgery through a right mini-thoracotomy approach.


Subject(s)
Cardiac Surgical Procedures/methods , Cardioplegic Solutions/therapeutic use , Heart Arrest, Induced/methods , Heart/physiopathology , Minimally Invasive Surgical Procedures/methods , Thoracotomy/methods , Adult , Aged , Arrhythmias, Cardiac/blood , Arrhythmias, Cardiac/etiology , Arrhythmias, Cardiac/physiopathology , Arrhythmias, Cardiac/prevention & control , Blood Transfusion/methods , Cardiac Output, Low/blood , Cardiac Output, Low/etiology , Cardiac Output, Low/physiopathology , Cardiac Output, Low/prevention & control , Cardiac Surgical Procedures/adverse effects , Creatine Kinase, MB Form/blood , Female , Glucose/therapeutic use , Heart/drug effects , Heart/physiology , Humans , Male , Mannitol/therapeutic use , Middle Aged , Minimally Invasive Surgical Procedures/adverse effects , Potassium Chloride/therapeutic use , Procaine/therapeutic use , Retrospective Studies , Thoracotomy/adverse effects , Troponin I/blood
4.
Eur J Cardiothorac Surg ; 32(2): 270-3, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17553687

ABSTRACT

BACKGROUND: Alternative cannulation sites such as the right/left axillary artery, the ascending aorta and aortic arch have been recently preferred to the femoral artery to improve neurologic outcome in patients undergoing surgery of the thoracic aorta. In 2004, we started to select the innominate artery as an arterial cannulation site for CPB and antegrade cerebral perfusion institution. Here we present our preliminary experience with 55 patients. METHODS: Between November 2004 and 2006, 55 patients (mean age 60+/-14 years) underwent surgery on the thoracic aorta using the innominate artery as a site for arterial cannulation. Indication for surgery was a degenerative aneurysm in 49 (89.1%), an acute type A dissection in 2 patients (3.6%), a post-dissection aneurysm in 3 (5.4%), a supravalvular aortic stenosis in 1 patient (1.8%). Operative procedure included total arch replacement (n=9), hemiarch replacement (n=6), ascending aorta replacement (n=21), Bentall procedure (n=18) and aortoplasty with patch (n=1). Mean CPB and cross clamp times were 131+/-60 and 95+/-29 min, respectively. Mean cerebral perfusion time was 54+/-26 min. RESULTS: The hospital mortality rate was 3.6%. There were no permanent neurologic dysfunction and one (1.8%) temporary neurological dysfunction. CONCLUSION: Our results with the cannulation of the innominate artery were encouraging. This provides the same advantages of the axillary artery cannulation with greater simplicity and avoiding extra surgical incisions which may be site for local complications. It may represent a valid option for CPB and antegrade cerebral perfusion institution in aortic procedures.


Subject(s)
Aorta, Thoracic/surgery , Aortic Aneurysm, Thoracic/surgery , Aortic Dissection/surgery , Brachiocephalic Trunk/surgery , Catheterization/methods , Adult , Aged , Aged, 80 and over , Aortic Dissection/mortality , Aortic Aneurysm, Thoracic/mortality , Cardiopulmonary Bypass/methods , Cerebrovascular Circulation/physiology , Female , Humans , Male , Middle Aged , Perfusion/methods , Postoperative Complications , Treatment Outcome
5.
Ann Thorac Surg ; 82(6): 2170-8, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17126130

ABSTRACT

BACKGROUND: C-reactive protein (CRP) is a known risk factor for cardiovascular events in the healthy population and in patients with coronary artery disease. High CRP levels before cardiac surgery are associated with worse short-term outcome, but its role after discharge home remains unknown. The study objective was to evaluate the effect of CRP on short-term and mid-term outcome after cardiac surgery. METHODS: From August 2000 to May 2004, values for preoperative CRP were available for 597 unselected patients undergoing cardiac operations. CRP was used to divide this cohort in two groups: a low inflammatory status (LHS) group of 354 patients with CRP of less than 0.5 mg/dL, and a high inflammatory status (HIS) group of 243 patients with a CRP of 0.5 mg/dL or more. Follow-up lasted a maximum of 3 years (median, 1.8 +/- 1.5 years) and was 92.6% complete. RESULTS: In-hospital mortality was 8.2% in the HIS group and 3.4% in the LIS group (odds ratio [OR], 2.61; p = 0.02). Incidence of postoperative infections was 16.5% in the HIS group and 5.1% in the LIS group (OR, 3.25; p = 0.0001). Sternal wound infections were also more frequent in the HIS group (10.7% versus 2.8%; OR, 3.43; p = 0.002). During follow-up, the HIS group had worse survival (88.5% +/- 2.9% versus 91.9% +/- 2.5%; OR, 1.93; p = 0.05) and a higher need of hospitalization for cardiac-related causes (73.6% +/- 6% versus 86.5% +/- 3.2%; OR, 1.82; p = 0.05). CONCLUSIONS: Patients undergoing cardiac surgery with a CRP level of 0.5 mg/dL or more are exposed to a higher risk of in-hospital mortality and postoperative infections. Despite surgical correction of cardiac disease, a high preoperative CRP value is an independent risk factor for mid-term survival and hospitalization for cardiac causes.


Subject(s)
C-Reactive Protein/analysis , Cardiac Surgical Procedures/mortality , Aged , Cardiac Surgical Procedures/adverse effects , Female , Hospitalization , Humans , Male , Predictive Value of Tests , Preoperative Care , Retrospective Studies , Surgical Wound Infection/epidemiology , Surgical Wound Infection/etiology , Survival Analysis , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL